학술논문

Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Document Type
article
Author
Peterlongo, PaoloChang-Claude, JennyMoysich, Kirsten BRudolph, AnjaSchmutzler, Rita KSimard, JacquesSoucy, PennyEeles, Rosalind AEaston, Douglas FHamann, UteWilkening, StefanChen, BowangRookus, Matti ASchmidt, Marjanka Kvan der Baan, Frederieke HSpurdle, Amanda BWalker, Logan CLose, FelicityMaia, Ana-TeresaMontagna, MarcoMatricardi, LauraLubinski, JanJakubowska, AnnaGarcia, Encarna B GómezOlopade, Olufunmilayo INussbaum, Robert LNathanson, Katherine LDomchek, Susan MRebbeck, Timothy RArun, Banu KKarlan, Beth YOrsulic, SandraLester, JennyChung, Wendy KMiron, AlexSouthey, Melissa CGoldgar, David EBuys, Saundra SJanavicius, RamunasDorfling, Cecilia Mvan Rensburg, Elizabeth JDing, Yuan ChunNeuhausen, Susan LHansen, Thomas VOGerdes, Anne-MarieEjlertsen, BentJønson, LarsOsorio, AnaMartínez-Bouzas, CristinaBenitez, JavierConway, Edye EBlazer, Kathleen RWeitzel, Jeffrey NManoukian, SiranoushPeissel, BernardZaffaroni, DanielaScuvera, GiuliettaBarile, MonicaFicarazzi, FilomenaMariette, FrederiqueFortuzzi, StefanoViel, AlessandraGiannini, GiuseppePapi, LauraMartayan, AlineTibiletti, Maria GraziaRadice, PaoloVratimos, AthanassiosFostira, FlorentiaGarber, Judy EDonaldson, AlanBrewer, CaroleFoo, ClaireEvans, D Gareth RFrost, DebraEccles, DianaBrady, AngelaCook, JackieTischkowitz, MarcAdlard, JulianBarwell, JulianWalker, LisaIzatt, LouiseSide, Lucy EKennedy, M JohnRogers, Mark TPorteous, Mary EMorrison, Patrick JPlatte, RadkaDavidson, RosemarieHodgson, Shirley VEllis, SteveCole, Trevorbehalf of EMBRACE, onGodwin, Andrew KClaes, KathleenVan Maerken, TomMeindl, AlfonsGehrig, AndreaSutter, Christian
Source
Cancer Epidemiology Biomarkers & Prevention. 24(1)
Subject
Health Services and Systems
Biomedical and Clinical Sciences
Health Sciences
Oncology and Carcinogenesis
Prevention
Human Genome
Genetics
Ovarian Cancer
Clinical Research
Cancer
Breast Cancer
Aging
Genetic Testing
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Adult
Breast Neoplasms
Cohort Studies
Female
Genes
BRCA1
Genes
BRCA2
Humans
Mutation
Ovarian Neoplasms
Polymorphism
Single Nucleotide
Retrospective Studies
Young Adult
EMBRACE
GEMO Study Collaborators
HEBON
KConFab Investigators
Medical and Health Sciences
Epidemiology
Biomedical and clinical sciences
Health sciences
Language
Abstract
BackgroundBRCA1 and BRCA2 mutation carriers are at substantially increased risk for developing breast and ovarian cancer. The incomplete penetrance coupled with the variable age at diagnosis in carriers of the same mutation suggests the existence of genetic and nongenetic modifying factors. In this study, we evaluated the putative role of variants in many candidate modifier genes.MethodsGenotyping data from 15,252 BRCA1 and 8,211 BRCA2 mutation carriers, for known variants (n = 3,248) located within or around 445 candidate genes, were available through the iCOGS custom-designed array. Breast and ovarian cancer association analysis was performed within a retrospective cohort approach.ResultsThe observed P values of association ranged between 0.005 and 1.000. None of the variants was significantly associated with breast or ovarian cancer risk in either BRCA1 or BRCA2 mutation carriers, after multiple testing adjustments.ConclusionThere is little evidence that any of the evaluated candidate variants act as modifiers of breast and/or ovarian cancer risk in BRCA1 or BRCA2 mutation carriers.ImpactGenome-wide association studies have been more successful at identifying genetic modifiers of BRCA1/2 penetrance than candidate gene studies.